Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab

被引：10
作者：
Hagel, Stefan
Jantsch, Jonathan [1 ]
Budde, Ulrich [2 ]
Kalden, Joachim R. [3 ]
Eckardt, Kai-Uwe
Veelken, Roland
机构：
[1] Univ Erlangen Nurnberg, IZKF, D-91054 Erlangen, Germany
[2] Aesculabor Hamburg, Hamburg, Germany
[3] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med 3, D-91054 Erlangen, Germany
来源：
THROMBOSIS AND HAEMOSTASIS | 2008年 / 100卷 / 01期
关键词：
D O I：
10.1160/TH08-02-0089
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：151 / 153
页数：3
相关论文
共 16 条
[1]   Immunotherapy for thrombotic thrombocytopenic purpura [J].
Cataland, SR ;
Wu, HFM .
CURRENT OPINION IN HEMATOLOGY, 2005, 12 (05) :359-363
[2]   Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? [J].
Cserti, Christine M. ;
Landaw, Stephen ;
Uhl, Lynne .
JOURNAL OF CLINICAL APHERESIS, 2007, 22 (01) :21-25
[3]   B-cell targeting in rheumatoid arthritis and other autoimmune diseases [J].
Edwards, JCW ;
Cambridge, G .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) :394-403
[4]   Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity [J].
Ferrari, Silvia ;
Scheiflinger, Friedrich ;
Rieger, Manfred ;
Mudde, Geert ;
Wolf, Martine ;
Coppo, Paul ;
Girma, Jean-Pierre ;
Azoulay, Elie ;
Brun-Buisson, Christian ;
Fakhouri, Fadi ;
Mira, Jean-Paul ;
Oksenhendler, Eric ;
Poullin, Pascale ;
Rondeau, Eric ;
Schleinitz, Nicolas ;
Schlemmer, Benoit ;
Teboul, Jean-Louis ;
Vanhille, Philippe ;
Vernant, Jean-Paul ;
Meyer, Dominique ;
Veyradier, Agnes .
BLOOD, 2007, 109 (07) :2815-2822
[5]   The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders [J].
Franchini, Massimo ;
Veneri, Dino ;
Lippi, Giuseppe ;
Stenner, Rachel .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (02) :119-125
[6]   Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the transfusion medicine/hemostasis clinical trials network with a systematic review of rituximab therapy for immune-mediated disorders [J].
George, JN ;
Woodson, RD ;
Kiss, JE ;
Kojouri, K ;
Vesely, SK .
JOURNAL OF CLINICAL APHERESIS, 2006, 21 (01) :49-56
[7]   Thrombotic thrombocytopenic purpura [J].
George, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (18) :1927-1935
[8]   B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].
Hauser, Stephen L. ;
Waubant, Emmanuelle ;
Arnold, Douglas L. ;
Vollmer, Timothy ;
Antel, Jack ;
Fox, Robert J. ;
Bar-Or, Amit ;
Panzara, Michael ;
Sarkar, Neena ;
Agarwal, Sunil ;
Langer-Gould, Annette ;
Smith, Craig H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688
[9]   Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia [J].
Heidel, Florian ;
Lipka, Daniel B. ;
von Auer, Charis ;
Huber, Christoph ;
Scharrer, Inge ;
Hess, Georg .
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (02) :228-233
[10]   ADAMTS13 turns 3 [J].
Levy, GG ;
Motto, DG ;
Ginsburg, D .
BLOOD, 2005, 106 (01) :11-17
12